These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 19432889)

  • 21. GITR activation induces an opposite effect on alloreactive CD4(+) and CD8(+) T cells in graft-versus-host disease.
    Muriglan SJ; Ramirez-Montagut T; Alpdogan O; Van Huystee TW; Eng JM; Hubbard VM; Kochman AA; Tjoe KH; Riccardi C; Pandolfi PP; Sakaguchi S; Houghton AN; Van Den Brink MR
    J Exp Med; 2004 Jul; 200(2):149-57. PubMed ID: 15249593
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Reinforcement of cancer immunotherapy by adoptive transfer of cblb-deficient CD8+ T cells combined with a DC vaccine.
    Lutz-Nicoladoni C; Wallner S; Stoitzner P; Pircher M; Gruber T; Wolf AM; Gastl G; Penninger JM; Baier G; Wolf D
    Immunol Cell Biol; 2012 Jan; 90(1):130-4. PubMed ID: 21383769
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Glucocorticoid-induced tumor necrosis factor receptor-related protein co-stimulation facilitates tumor regression by inducing IL-9-producing helper T cells.
    Kim IK; Kim BS; Koh CH; Seok JW; Park JS; Shin KS; Bae EA; Lee GE; Jeon H; Cho J; Jung Y; Han D; Kwon BS; Lee HY; Chung Y; Kang CY
    Nat Med; 2015 Sep; 21(9):1010-7. PubMed ID: 26280119
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Regulation of murine inflammatory bowel disease by CD25+ and CD25- CD4+ glucocorticoid-induced TNF receptor family-related gene+ regulatory T cells.
    Uraushihara K; Kanai T; Ko K; Totsuka T; Makita S; Iiyama R; Nakamura T; Watanabe M
    J Immunol; 2003 Jul; 171(2):708-16. PubMed ID: 12847237
    [TBL] [Abstract][Full Text] [Related]  

  • 25. GITR ligand fusion protein agonist enhances the tumor antigen-specific CD8 T-cell response and leads to long-lasting memory.
    Durham NM; Holoweckyj N; MacGill RS; McGlinchey K; Leow CC; Robbins SH
    J Immunother Cancer; 2017; 5():47. PubMed ID: 28649380
    [TBL] [Abstract][Full Text] [Related]  

  • 26. GITR signaling potentiates airway hyperresponsiveness by enhancing Th2 cell activity in a mouse model of asthma.
    Motta AC; Vissers JL; Gras R; Van Esch BC; Van Oosterhout AJ; Nawijn MC
    Respir Res; 2009 Oct; 10(1):93. PubMed ID: 19811658
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Synergistic enhancement of antitumor immunity with adoptively transferred tumor-specific CD4+ and CD8+ T cells and intratumoral lymphotactin transgene expression.
    Huang H; Li F; Gordon JR; Xiang J
    Cancer Res; 2002 Apr; 62(7):2043-51. PubMed ID: 11929823
    [TBL] [Abstract][Full Text] [Related]  

  • 28. GITR ligation enhances functionality of tumor-infiltrating T cells in hepatocellular carcinoma.
    van Beek AA; Zhou G; Doukas M; Boor PPC; Noordam L; Mancham S; Campos Carrascosa L; van der Heide-Mulder M; Polak WG; Ijzermans JNM; Pan Q; Heirman C; Mahne A; Bucktrout SL; Bruno MJ; Sprengers D; Kwekkeboom J
    Int J Cancer; 2019 Aug; 145(4):1111-1124. PubMed ID: 30719701
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Costimulation via glucocorticoid-induced TNF receptor in both conventional and CD25+ regulatory CD4+ T cells.
    Kanamaru F; Youngnak P; Hashiguchi M; Nishioka T; Takahashi T; Sakaguchi S; Ishikawa I; Azuma M
    J Immunol; 2004 Jun; 172(12):7306-14. PubMed ID: 15187106
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Helper-independent, L-selectinlow CD8+ T cells with broad anti-tumor efficacy are naturally sensitized during tumor progression.
    Peng L; Kjaergaard J; Plautz GE; Weng DE; Shu S; Cohen PA
    J Immunol; 2000 Nov; 165(10):5738-49. PubMed ID: 11067932
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Magnetic targeting of adoptively transferred tumour-specific nanoparticle-loaded CD8
    Sanz-Ortega L; Portilla Y; Pérez-Yagüe S; Barber DF
    J Nanobiotechnology; 2019 Aug; 17(1):87. PubMed ID: 31387604
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Agonist anti-GITR antibody significantly enhances the therapeutic efficacy of Listeria monocytogenes-based immunotherapy.
    Shrimali R; Ahmad S; Berrong Z; Okoev G; Matevosyan A; Razavi GSE; Petit R; Gupta S; Mkrtichyan M; Khleif SN
    J Immunother Cancer; 2017 Aug; 5(1):64. PubMed ID: 28807056
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tumor-specific crosslinking of GITR as costimulation for immunotherapy.
    Burckhart T; Thiel M; Nishikawa H; Wüest T; Müller D; Zippelius A; Ritter G; Old L; Shiku H; Renner C
    J Immunother; 2010; 33(9):925-34. PubMed ID: 20948444
    [TBL] [Abstract][Full Text] [Related]  

  • 34. GITR ligation blocks allograft protection by induced CD25+CD4+ regulatory T cells without enhancing effector T-cell function.
    Bushell A; Wood K
    Am J Transplant; 2007 Apr; 7(4):759-68. PubMed ID: 17391121
    [TBL] [Abstract][Full Text] [Related]  

  • 35. CD4
    Imai N; Tawara I; Yamane M; Muraoka D; Shiku H; Ikeda H
    Cancer Sci; 2020 Jun; 111(6):1958-1968. PubMed ID: 32304127
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Key role of the GITR/GITRLigand pathway in the development of murine autoimmune diabetes: a potential therapeutic target.
    You S; Poulton L; Cobbold S; Liu CP; Rosenzweig M; Ringler D; Lee WH; Segovia B; Bach JF; Waldmann H; Chatenoud L
    PLoS One; 2009 Nov; 4(11):e7848. PubMed ID: 19936238
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Therapeutic glucocorticoid-induced TNF receptor-mediated amplification of CD4+ T cell responses enhances antiparasitic immunity.
    Haque A; Stanley AC; Amante FH; Rivera Fde L; Zhou Y; Kuns RD; Yardley V; Sakaguchi S; Hill GR; Engwerda CR
    J Immunol; 2010 Mar; 184(5):2583-92. PubMed ID: 20139272
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Enhancing Dendritic Cell-based Immunotherapy with IL-2/Monoclonal Antibody Complexes for Control of Established Tumors.
    Kim MT; Richer MJ; Gross BP; Norian LA; Badovinac VP; Harty JT
    J Immunol; 2015 Nov; 195(9):4537-44. PubMed ID: 26408669
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Functional impairment of CD8(+) T cells by regulatory T cells during persistent retroviral infection.
    Dittmer U; He H; Messer RJ; Schimmer S; Olbrich AR; Ohlen C; Greenberg PD; Stromnes IM; Iwashiro M; Sakaguchi S; Evans LH; Peterson KE; Yang G; Hasenkrug KJ
    Immunity; 2004 Mar; 20(3):293-303. PubMed ID: 15030773
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A combination of chemoimmunotherapies can efficiently break self-tolerance and induce antitumor immunity in a tolerogenic murine tumor model.
    Ko HJ; Kim YJ; Kim YS; Chang WS; Ko SY; Chang SY; Sakaguchi S; Kang CY
    Cancer Res; 2007 Aug; 67(15):7477-86. PubMed ID: 17671218
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.